Kirana Megatara Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Kirana Megatara Tbk. trades at Rp254 (market cap 2.15T, 253.6K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Kirana Megatara Tbk. is far larger — about 20.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KMTR | SCPI | |
|---|---|---|
Market Cap | 2.15T | 104.4B |
Volume | 253.6K | — |
Lot | 2.54K | — |
Turnover | 64.38M | — |
Average Price | 253.86 | — |
Value | 64.38M | — |
Indicative Equilibrium Price | 254 | — |
Indicative Equilibrium Volume | 200 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Kirana Megatara Tbk (the Company) was established based on Notarial Deed of Ny. Rukmasanti Hardjasatya, S.H., No. 63 dated 25 March 1991,
Read more on KMTR →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →